El dispositivos de autocontrol de glucosa en sangre tamaño del mercado Se prevé que crezca de 9.500 millones de dólares en 2023 a 22.4 millones de dólares en 2031; Se estima que el mercado registrará una tasa compuesta anual del 11,3% durante 2023-2031. La creciente preferencia por el control remoto de la glucosa entre la población diabética impulsa el crecimiento del mercado de dispositivos de autocontrol de la glucosa en sangre. Sin embargo, las retiradas de productos impiden el crecimiento del mercado.
Impulsores de crecimiento:< /strong>
Creciente preferencia por el control remoto de glucosa entre las personas diabéticas
La industria alimentaria y La Administración de Medicamentos (FDA) respalda la verificación remota de glucosa mediante el uso de un medidor de glucosa que ofrece una lectura precisa. Algunos medidores de glucosa en sangre de uso doméstico tienen capacidades integradas de transmisión de datos inalámbricas que facilitan la monitorización remota de la glucosa en sangre del paciente, lo que brinda comodidad y facilidad. Por lo tanto, la FDA fomenta el apoyo regulatorio y las políticas que permitan a los pacientes diabéticos realizar autodiagnósticos utilizando medidores de glucosa en sangre de uso doméstico.
El sistema "Cobas Pulse" de Abbott es un ejemplo de solución inteligente. medidor de autoglucemia. Es un medidor de glucosa de alto rendimiento combinado con la tecnología "Cobas Infinity" para ofrecer una solución de software de gestión digital y segura. Por lo tanto, la creciente preferencia de los dispositivos de control remoto de glucosa entre las personas diabéticas tendrá un impacto positivo en el tamaño del mercado de dispositivos de autocontrol de glucosa en sangre, facilitando la expansión del mercado.
Segmentación y alcance del informe:
El dispositivos de autocontrol de glucosa en sangre análisis de mercado se ha realizado considerando lo siguiente segmentos: producto, aplicación, sitio de prueba y usuario final.
Análisis segmentario: h3>
Por producto, el mercado se segmenta en tiras reactivas, glucómetros, lancetas y otros. El segmento de tiras reactivas tuvo la mayor participación de mercado de dispositivos de autocontrol de glucosa en sangre en 2023 y se prevé que registre la CAGR más alta del 11,8 % durante el 2021-2031. La Iniciativa Clinton de Acceso a la Salud (CHAI), publicada en octubre de 2021, reveló que las tiras reactivas generan los principales ingresos para el mercado de dispositivos de autocontrol de glucosa en sangre. Esto se debe a que un gran número de pacientes diabéticos requieren varias tiras reactivas al día, lo que genera un alto volumen de consumo. Además, muchos proveedores ofrecen medidores de glucosa de forma gratuita a las personas diabéticas, lo que es responsable de impulsar las ventas de tiras reactivas. Para acelerar aún más el consumo de ventas de tiras reactivas, los proveedores limitan la compatibilidad de las tiras reactivas patentadas con modelos de medidores particulares, de modo que las tiras reactivas no funcionan con otras marcas de medidores o incluso con otros modelos dentro de la misma marca. span>
Dispositivos de autocontrol de glucosa en sangre Tendencias del mercado
< span>Dispositivos de autocontrol de glucosa en sangre basados en telemedicina
En la práctica médica convencional, se sugirieron modificaciones en el estilo de vida y cambios de medicación durante las visitas de consulta. En diversas circunstancias, estas visitas cara a cara pueden no ser factibles y resultar costosas. Los avances recientes en las tecnologías de telemedicina no solo han surgido como plataformas prometedoras para brindar servicios de control de la diabetes, sino que también ayudan a reducir la asignación innecesaria de recursos de atención médica. Se han desarrollado dispositivos de autocontrol de glucosa en sangre basados en telemedicina con capacidades de transmisión, lo que permite que estos dispositivos se vinculen a aplicaciones o sitios web de teléfonos inteligentes. Los pacientes pueden medir cómodamente sus niveles de glucosa en sangre por sí mismos y compartir los resultados con su equipo de atención médica en tiempo real. Por ejemplo, la "herramienta de software G6" de la compañía Dexcom utilizada por los médicos del Centro Barbara Davis en Colorado brinda atención virtual a pacientes diabéticos para que puedan autocontrolar sus niveles de glucosa. Además, está clínicamente probado que el G6 de Dexcom reduce la A1C, reduce los niveles de hiper e hipoglucemia y proporciona un conjunto de alertas protectoras. El producto está disponible para pacientes de habla inglesa y española. Por lo tanto, la popularidad de estos dispositivos de monitoreo de glucosa en sangre basados en telemedicina puede brindar oportunidades lucrativas para el crecimiento del mercado de dispositivos de autocontrol de glucosa en sangre.
Análisis Regional :
El alcance delinforme de mercado de dispositivos de autocontrol de glucosa en sangre implica América del Norte, Europa y Asia. Pacífico, Sur y Pacífico Centroamérica y Medio Oriente y Asia. África. En 2022, América del Norte tenía la mayor cuota de mercado de dispositivos de autocontrol de glucosa en sangre. El creciente número de lanzamientos de productos por parte de las principales empresas y la presencia de actores clave del mercado favorecen el mercado en América del Norte. Estados Unidos es el mayor contribuyente al mercado en América del Norte debido a la presencia de un gran grupo de diabéticos. población y organismos reguladores para desarrollar y aprobar dispositivos de autocontrol de glucosa en sangre en esta región.
Desarrollos de la industria y oportunidades futuras: strong>
Los dispositivos de autocontrol de glucosa en sangre pronóstico del mercado puede ayudar a las partes interesadas en este mercado a planificar sus estrategias de crecimiento. A continuación se enumeran algunos desarrollos estratégicos realizados por los principales actores \
que operan en el mercado:
- •En marzo de 2023, Astellas Pharma I 1`1` bvp. pp, "TempoSmart" y una pluma de insulina precargada, "Tempo Pen", que trabajan en conjunto para brindar orientación personalizada a adultos que padecen diabetes. La aplicación fue desarrollada en asociación con la empresa Welldoc y es una iteración de marca privada de "BlueStar" de la empresa, una aplicación de control de la diabetes personalizada para recibir datos relacionados con la dosis de insulina del Botón inteligente Tempo.
Panorama competitivo y empresas clave:
< span>B. Braun SE, F. Hoffmann-La-Roche, LifeScan Inc., Medtronic, Abbott, Ypsomed Holding AG, Sensionics, Nipro Corp, GE Healthcare y Terumo Corp se encuentran entre las empresas destacadas perfiladas en el self. -Informe de mercado de dispositivos de seguimiento de glucosa en sangre. Estas empresas se centran en desarrollar nuevas tecnologías, actualizar productos existentes y ampliar su presencia geográfica para satisfacer la creciente demanda de los consumidores en todo el mundo.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Cut Flowers Market
- Maritime Analytics Market
- Batter and Breader Premixes Market
- Lyophilization Services for Biopharmaceuticals Market
- Artificial Turf Market
- Oxy-fuel Combustion Technology Market
- Travel Vaccines Market
- Grant Management Software Market
- Sexual Wellness Market
- Artificial Intelligence in Healthcare Diagnosis Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The testing strips segment held the largest share of the market in the global self-monitoring blood glucose devices market and held the largest market share in 2023.
Key factors that are driving the growth of this market are the rising preference for remote glucose checking among diabetic population is expected to boost the market growth for the self-monitoring blood glucose devices over the years.
The type 2 diabetes segment dominated the global self-monitoring blood glucose devices market and held the largest market share in 2023.
Self-monitoring blood glucose (SMBGDs) is an important component of modern therapy to manage diabetes mellitus. SMBG has been recommended for people with diabetes and healthcare professionals to achieve a specific level of glycemic control and prevent hypoglycemia.
The CAGR value of the self-monitoring blood glucose devices market during the forecasted period of 2023-2031 is 11.3%.
The self-monitoring blood glucose devices market majorly consists of the players such B. Braun SE, F. Hoffmann-La-Roche, LifeScan Inc., Medtronic, Abbott, Ypsomed Holding AG, Sensionics, Nipro Corp, GE Healthcare, Terumo Corp, and amongst others.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Self-Monitoring Blood Glucose Devices (SMBGDs) Market
- B. Braun SE
- F. Hoffmann-La-Roche
- LifeScan Inc.
- Medtronic
- Abbott
- Ypsomed Holding AG
- Sensionics
- Nipro Corp
- GE Healthcare
- Terumo Corp
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.